Pricing Log in Create free account
Friday 6 November 2026 Export ILMN’s income statement to Excel — free account

Illumina, Inc.

ILMN Healthcare Diagnostics & Research

Illumina, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $4.3 billion, down 0.66% from fiscal 2024.

Revenue
+4.15%
EPS
+49.0%
Free cash flow
+49.8%
Total debt
+80.0%

Quarter to September 2026, against a year earlier

209.82 16.72 −7.38%
Market cap
$31.5B
P/E
35.6×
Fwd P/E
46.4×
Dividend yield
—
F-score
8/9
Altman Z
4.39
Beneish M
−2.51
Dividend safety
n/a
Overview Business Profile Earnings & Analysis
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios
Segments Valuation Filings

Illumina, Inc. (ILMN) EV/EBITDA

Alert me on EV/EBITDA

As of 5 November 2026, Illumina, Inc. (ILMN) trades at a EV/EBITDA of 26.4×. Over the past ten years it has ranged from 0.0× (June 2025) to 395× (January 2022); the current reading is higher than 38% of that period. That is above the Diagnostics & Research industry median of 23.4× and above the Healthcare sector median of 8.4×.

EV/EBITDA, daily

Embed this chart

Annual newest first

Period EV/EBITDA Change
FY2025 19.2× —
FY2024 0.0× —
FY2023 0.0× —
FY2022 0.0× —
FY2021 355× 461.20%
FY2020 63.3× 69.13%
FY2019 37.5× (1.12%)
FY2018 37.9× (3.74%)
FY2017 39.3× 61.87%
FY2016 24.3× (29.29%)

Quarterly newest first

Period EV/EBITDA Change
Sep 2026 34.1× 44.12%
Jun 2026 23.7× 35.05%
Mar 2026 17.5× (8.62%)
Dec 2025 19.2× 37.32%
43 more quarters

Against its own ten years

Low 0.0× High 395×
Ten-year median 33.6×
Current reading's percentile 38

EV/EBITDA against peers

Company EV/EBITDA
GH Guardant Health, Inc. compare n/m
DGX Quest Diagnostics Incorporated compare 14.2×
LH Labcorp Holdings Inc. compare 15.6×
IQV IQVIA Holdings Inc. compare 16.5×
ILMN Illumina, Inc. 26.4×
A Agilent Technologies, Inc. compare 26.4×
MTD Mettler-Toledo International, Inc. compare 27.4×
IDXX IDEXX Laboratories, Inc. compare 31.8×
WAT Waters Corporation compare 51.9×
Diagnostics & Research industry median 23.4×
Healthcare sector median 8.4×
Market median 10.9×

What EV/EBITDA is

Enterprise Value over EBITDA tells an investor how the market values a whole company, with debt added and cash taken off, against its operating earnings.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ EBITDA (TTM)

The full definition of EV/EBITDA →

More on ILMN